Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

CMS introduces new models to lower drug prices in Part D, Medicare Advantage

CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to lower prescription drug prices in Medicare Part D and introduced several updates to Medicare Advantage (MA) plans.

Thumbnail

CMS proposes 2020 payment notice

The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year, including making changes to the individual health insurance exchange and qualified health plan provisions.

Thumbnail

Healthcare spending on wearables to reach $60B by 2023

Healthcare spending on wearables is expected to reach $60 billion by 2023 as the technology becomes more popular within the medical industry, according to a recent report by Juniper Research.

Thumbnail

More than half of physicians are burned out or depressed

Physicians are feeling stressed out, with 44 percent reporting they feel burned out and 15 percent reporting they are depressed, according to a recent report from Medscape.

Thumbnail

Healthcare is the hottest stock sector

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Thumbnail

Congress to look into drug prices

Rising drug prices have caught the attention of the Congressional Committee on Oversight and Reform, which announced it will open a “sweeping” drug price investigation.

Thumbnail

Hospitals deeply impacted by rising drug prices

Americans are concerned about higher drug costs impacting their wallets, but hospitals and health systems have also been feeling the pinch, according to a recent study from hospital groups including the American Hospital Association.

Thumbnail

Makers of OxyContin misled patients, doctors on addiction dangers

An American family that has become one of the wealthiest in the nation due to sales of the powerful opioid OxyContin misled doctors and patients about the dangers associated with the drug, The New York Times reported.

Displaying 2905 - 2912 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup